Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 5,990.00
-30.00 (-0.50%)
At close: Jun 5, 2026
Wonbiogen Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 7,042 | 6,615 | 5,690 | 5,497 | 3,206 | -716.2 |
Depreciation & Amortization | 1,516 | 1,507 | 1,647 | 1,569 | 1,199 | 881.58 |
Loss (Gain) From Sale of Assets | 125.61 | 124.47 | 1.38 | 7.13 | -11.69 | 57.7 |
Asset Writedown & Restructuring Costs | 161.78 | 161.78 | 196.65 | - | - | - |
Loss (Gain) From Sale of Investments | 90.5 | 90.5 | 32.64 | -48.67 | 200 | - |
Loss (Gain) on Equity Investments | 146.21 | 146.62 | -42.83 | 60.51 | - | - |
Stock-Based Compensation | - | - | - | - | - | 8.11 |
Provision & Write-off of Bad Debts | -330.14 | -273.01 | -147.54 | 246.2 | 408.88 | 524.98 |
Other Operating Activities | 175.86 | -17.29 | -471.27 | 938.55 | 1,960 | 2,641 |
Change in Accounts Receivable | 2.13 | -811.57 | 197.36 | -2,521 | -224.68 | -256.06 |
Change in Inventory | -258.46 | -374.34 | 1,540 | -1,215 | -936.87 | -2,361 |
Change in Accounts Payable | 404 | 566.36 | 207.79 | 452.82 | -133.58 | 741.99 |
Change in Unearned Revenue | 78.53 | 18.52 | 2.24 | 23.12 | -46.45 | 16.16 |
Change in Income Taxes | 0.01 | - | - | - | - | 31.85 |
Change in Other Net Operating Assets | 695.69 | 729.57 | -3.47 | -175.27 | 161.35 | -487.8 |
Operating Cash Flow | 9,850 | 8,483 | 8,850 | 4,835 | 5,782 | 1,082 |
Operating Cash Flow Growth | 28.74% | -4.14% | 83.02% | -16.38% | 434.37% | 35.58% |
Capital Expenditures | -6,445 | -1,972 | -648.41 | -1,646 | -6,494 | -2,336 |
Sale of Property, Plant & Equipment | 92.26 | 92.26 | 0.4 | 121.73 | 0.12 | 1,050 |
Sale (Purchase) of Intangibles | -48.97 | -49.68 | -16.22 | -88.39 | -74.16 | -1.96 |
Investment in Securities | 2,453 | -3,895 | 3,002 | -775.82 | 723.24 | -1,098 |
Other Investing Activities | -12.24 | -72.69 | -4 | 22.14 | -6.78 | -95.43 |
Investing Cash Flow | -3,961 | -5,897 | 2,427 | -2,589 | -5,852 | -2,481 |
Short-Term Debt Issued | - | - | - | 500 | 59.89 | - |
Long-Term Debt Issued | - | - | - | 500 | - | 7,984 |
Total Debt Issued | 2,000 | - | - | 1,000 | 59.89 | 7,984 |
Short-Term Debt Repaid | - | -200 | -500 | -500 | -59.89 | -1,420 |
Long-Term Debt Repaid | - | -244.47 | -5,966 | -2,797 | -303.66 | -240.47 |
Total Debt Repaid | -816.15 | -444.47 | -6,466 | -3,297 | -363.55 | -1,660 |
Net Debt Issued (Repaid) | 1,184 | -444.47 | -6,466 | -2,297 | -303.66 | 6,324 |
Issuance of Common Stock | - | - | - | 218.33 | - | 411.26 |
Repurchase of Common Stock | -1,917 | -383.05 | - | - | -2,996 | - |
Dividends Paid | -709.19 | -709.19 | -709.19 | -349.55 | - | - |
Other Financing Activities | - | - | -10 | -1.32 | -1,000 | -163.81 |
Financing Cash Flow | -1,442 | -1,537 | -7,186 | -2,429 | -4,300 | 6,571 |
Foreign Exchange Rate Adjustments | 38.57 | 14.51 | 68 | -6.72 | -75.95 | 1.2 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | 1,302 |
Net Cash Flow | 4,485 | 1,064 | 4,159 | -189.86 | -4,445 | 6,476 |
Free Cash Flow | 3,405 | 6,512 | 8,201 | 3,189 | -711.95 | -1,254 |
Free Cash Flow Growth | -50.44% | -20.60% | 157.16% | - | - | - |
Free Cash Flow Margin | 9.39% | 18.48% | 26.94% | 10.77% | -2.66% | -7.08% |
Free Cash Flow Per Share | 483.11 | 918.17 | 1156.00 | 419.31 | -98.94 | -180.51 |
Cash Interest Paid | 26.39 | 25.98 | 34.04 | 83.89 | 27.55 | 17.96 |
Cash Income Tax Paid | 1,286 | 1,240 | 1,375 | 1,041 | -55.27 | 222.5 |
Levered Free Cash Flow | 1,650 | 4,656 | 6,801 | 1,293 | -4,009 | -16,614 |
Unlevered Free Cash Flow | 1,677 | 4,681 | 6,837 | 1,366 | -3,213 | -16,345 |
Change in Working Capital | 921.9 | 128.55 | 1,944 | -3,435 | -1,180 | -2,315 |